ISOTYPE CHARACTERIZATION OF ANTI-INFLIXIMAB ANTIBODIES IN PEDIATRIC PATIENTS WITH RHEUMATIC DISEASES TREATED WITH INFLIXIMAB

被引：0
|
作者：
Kosmac, M. [1 ,2 ,3 ]
Toplak, N. [3 ]
Simonini, G. [4 ,5 ]
Cimaz, R. [4 ,5 ]
Serbec, V. Curin [1 ,2 ]
Avcin, T. [3 ]
机构：
[1] Blood Transfus Ctr Slovenia, Dept Prod Diagnost Reagents & Res, Ljubljana, Slovenia
[2] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 61000, Slovenia
[3] Univ Childrens Hosp, Univ Med Ctr, Dept Allergol Rheumatol & Clin Immunol, Ljubljana, Slovenia
[4] Anna Meyer Childrens Hosp, Rheumatol Unit, Florence, Italy
[5] Univ Florence, Florence, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.2260
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：255 / 255
页数：1
相关论文
共 50 条
  • [1] Anti-infliximab antibodies in pediatric patients with rheumatic diseases treated with infliximab
    Kosmac, Miha
    Avcin, Tadej
    Toplak, Natasa
    Simonini, Gabriele
    Cimaz, Rolando
    Serbec, Vladka Curin
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 385 - 386
  • [2] Exploring the Binding Sites of Anti-Infliximab Antibodies in Pediatric Patients With Rheumatic Diseases Treated With Infliximab
    Kosmac, Miha
    Avcin, Tadej
    Toplak, Natasa
    Simonini, Gabriele
    Cimaz, Rolando
    Serbec, Vladka Curin
    [J]. PEDIATRIC RESEARCH, 2011, 69 (03) : 243 - 248
  • [3] Exploring the Binding Sites of Anti-Infliximab Antibodies in Pediatric Patients With Rheumatic Diseases Treated With Infliximab
    Miha Kosmač
    Tadej Avčin
    Nataša Toplak
    Gabriele Simonini
    Rolando Cimaz
    Vladka Čurin Šerbec
    [J]. Pediatric Research, 2011, 69 : 243 - 248
  • [4] Detectable Anti-Infliximab Antibodies in Children Treated with Infliximab for Rheumatic Diseases
    Aeschlimann, Florence A.
    Hofer, Kevin
    Schneider, Elvira Cannizzaro
    Schroeder, Silke
    Lauener, Roger
    van der Kleij, Desiree
    Rispens, Theo
    Saurenmann, R. K.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S7 - S7
  • [5] Anti-infliximab antibodies in RA patients treated with infliximab.
    Wolbink, GJ
    Lems, WF
    Nurmohamed, MT
    Vis, M
    Voskuyl, AE
    Stapel, S
    de Groot, E
    Tak, PP
    Dijkmans, BA
    Aarden, L
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S187 - S187
  • [6] Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies
    Svenson, M.
    Geborek, P.
    Saxne, T.
    Bendtzen, K.
    [J]. RHEUMATOLOGY, 2007, 46 (12) : 1828 - 1834
  • [7] Therapeutic drug monitoring of infliximab biosimilar and anti-infliximab antibodies in inflammatory diseases
    Elberdin, Laida
    Outeda, Maria
    Mateos, Maria
    Martinez, Cristina
    Salvador, Pilar
    Angeles Porta, Maria
    Isabel Martin, Maria
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 338 - 339
  • [8] Commentary: detection of infliximab levels and anti-infliximab antibodies
    Seow, C. H.
    Panaccione, R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (01) : 153 - 154
  • [9] Anti-infliximab antibodies developed in patients treated for severe hidradenitis suppurativa
    Peeters, M. -A.
    Laffitte, E.
    [J]. EXPERIMENTAL DERMATOLOGY, 2016, 25 : 12 - 12
  • [10] Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD
    Steenholdt, C.
    Brynskov, J.
    Bendtzen, K.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (05) : 499 - 500
12345